Type 2 diabetes mellitus, independent of insulin use, is associated with an increased risk of cardiac complications after vascular surgery

Anaesthesia and Intensive Care

Volumn 41, Issue 5, 2013, Pages 584-590

  Bakker, E J ^a   Valentijn, T M ^a   Van De Luijtgaarden, K M ^a   Hoeks, S E ^a   Voute, M T ^a   Goncalves, F B ^a   Verhagen, H J ^a   Stolker, R J ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Diabetes mellitus: type 2; Surgery: vascular; Surgical complications: cardiac

Indexed keywords

TROPONIN;

ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MORTALITY; COMORBIDITY; CONGESTIVE HEART FAILURE; ELECTIVE SURGERY; FEMALE; HEART ARRHYTHMIA; HEART DEATH; HEART INFARCTION; HUMAN; INSULIN TREATMENT; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; POSTOPERATIVE COMPLICATION; RETROSPECTIVE STUDY; SURGICAL RISK; VASCULAR SURGERY;

EID: 84885404042     PISSN: 0310057X     EISSN: 14480271     Source Type: Journal    
DOI: 10.1177/0310057x1304100515     Document Type: Article

References (21)

1. Lee TH, Marcantonio ER, Mangione CM, Thomas EJ, Polanczyk CA, Cook EF et al. Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery. Circulation 1999; 100:1043-1049.
2. Bertges DJ, Goodney PP, Zhao Y, Schanzer A, Nolan BW, Likosky DS et al. The Vascular Study Group of New England Cardiac Risk Index (VSG-CRI) predicts cardiac complications more accurately than the Revised Cardiac Risk Index in vascular surgery patients. J Vasc Surg 2010; 52:674-683, 683.e1-683.e.
3. Beckman JA, Creager MA, Libby P. Diabetes and atherosclerosis: epidemiology, pathophysiology, and management. JAMA 2002; 287:2570-2581.
4. Diagnosis and classification of diabetes mellitus. Diabetes Care 2010; 33 Suppl 1:S62-69.
5. Hamdan AD, Saltzberg SS, Sheahan M, Froelich J, Akbari CM, Campbell DR et al. Lack of association of diabetes with increased postoperative mortality and cardiac morbidity: results of 6565 major vascular operations. Arch Surg 2002; 137:417-421.
6. Boersma E, Kertai MD, Schouten O, Bax JJ, Noordzij P, Steyerberg EW et al. Perioperative cardiovascular mortality in noncardiac surgery: validation of the Lee cardiac risk index. Am J Med 2005; 118:1134-1141.
7. Valentijn TM, Hoeks SE, Martienus KA, Bakker EJ, van de Luijtgaarden KM, Verhagen HJ et al. Impact of haemoglobin concentration on cardiovascular outcome after vascular surgery: a retrospective observational cohort study. Eur J Anaesthesiol 2013; n/a:[Epub ahead of print].
8. Bakker EJ, Valentijn TM, Hoeks SE, van de Luijtgaarden KM, Leebeek FW, Verhagen HJM et al. ABO blood type does not influence the risk of cardiovascular complications and mortality after vascular surgery. Eur J Vasc Endovasc Surg 2013; 45:256-260.
9. Valentijn TM, Hoeks SE, Bakker EJ, Voûte MT, Chonchol M, van de Luijtgaarden KM et al. Influence of aortic valve calcium on outcome in patients undergoing peripheral vascular surgery. Am J Cardiol 2012; 110:1195-1199.
10. van Kuijk JP, Flu WJ, Chonchol M, Valentijn TM, Verhagen HJ, Bax JJ et al. Elevated preoperative phosphorus levels are an independent risk factor for cardiovascular mortality. Am J Nephrol 2010; 32:163-168.
11. Shaw JE, Sicree RA, Zimmet PZ. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract 2010; 87:4-14.
12. Kannel WB, McGee DL. Diabetes and cardiovascular risk factors: the Framingham study. Circulation 1979; 59:8-13.
13. Geraldes P, King GL. Activation of protein kinase C isoforms and its impact on diabetic complications. Circ Res 2010; 106:1319-1331.
14. Ramasamy R, Goldberg IJ. Aldose reductase and cardiovascular diseases, creating human-like diabetic complications in an experimental model. Circ Res 2010; 106:1449-1458.
15. Yan SF, Ramasamy R, Schmidt AM. The RAGE axis: a fundamental mechanism signaling danger to the vulnerable vasculature. Circ Res 2010; 106:842-853.
16. DeFronzo RA. Insulin resistance: a multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidaemia and atherosclerosis. Neth J Med 1997; 50:191-197.
17. Eagle KA, Coley CM, Newell JB, Brewster DC, Darling RC, Strauss HW et al. Combining clinical and thallium data optimizes preoperative assessment of cardiac risk before major vascular surgery. Ann Intern Med 1989; 110:859-866.
18. Bolsin SNC, Raineri F, Lo SK, Cattigan C, Arblaster R, Colson M. Cardiac complications and mortality rates in diabetic patients following non-cardiac surgery in an Australian teaching hospital. Anaesth Intensive Care 2009; 37:561-567.
19. Eagle KA, Berger PB, Calkins H, Chaitman BR, Ewy GA, Fleischmann KE et al. ACC/AHA guideline update for perioperative cardiovascular evaluation for noncardiac surgery - executive summary a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1996 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery). Circulation 2002; 105:1257-1267.
20. Bolliger D, Seeberger MD, Lurati Buse G, Christen P, Seeberger E, Ruppen W et al. The influence of pre-admission hypoglycaemic therapy on cardiac morbidity and mortality in type 2 diabetic patients undergoing major non-cardiac surgery: a prospective observational study. Anaesthesia 2012; 67:149-157.
21. Flu WJ, Schouten O, van Kuijk JP, Poldermans D. Perioperative cardiac damage in vascular surgery patients. Eur J Vasc Endovasc Surg 2010; 40:1-8.